Unit 1

8 Turbo Road Email: projects@scidev.com.au

Kings Park NSW 2148 Australia Website: www.scidev.com.au
ABN 25 001 150 849 ASX code: SDV

Companies Announcements Office

Australian Stock Exchange

19 November 2019

Exercise of Options, Share Issue and Appendix 3B

SciDev Ltd (ASX:SDV, SciDev or the Company) is pleased to advise that Managing Director and
CEO Lewis Utting has today exercised 500,000 of the Company’s $0.25 exercise price options,
contributing additional working capital of $125,000 to the Company.
An Appendix 3B New Issues Announcement is attached, which addresses this and other option
exercises and a share issue to a service provider.

On behalf of SciDev Ltd

Heath Roberts
Company Secretary
 Appendix 3B
New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12,
04/03/13

Name of entity

SciDev Ltd (ASX : SDV)

ABN
25 001 150 849

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of +securities issued or to Fully Paid Ordinary Shares

be issued

2 Number of +securities issued or 742,307

to be issued (if known) or
maximum number which may be
issued

3 Principal terms of the +securities Rank equally with the Company’s fully paid
(e.g. if options, exercise price ordinary shares quoted and trading as ‘SDV’
and expiry date; if partly paid
+securities, the amount
outstanding and due dates for
payment; if +convertible
securities, the conversion price
and dates for conversion)

+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 1

Appendix 3B
New issue announcement

4 Do the +securities rank equally in Yes. Refer 3 above

all respects from the +issue date
with an existing +class of quoted
+securities?

If the additional +securities do

not rank equally, please state:
• the date from which they do
• the extent to which they
participate for the next
dividend, (in the case of a
trust, distribution) or interest
payment
• the extent to which they do
not rank equally, other than
in relation to the next
dividend, distribution or
interest payment

5 Issue price or consideration $0.25 per share for 550,000 shares

(conversion of $0.25 options)
$0.26 per share for 192,307 shares to service
provider

6 Purpose of the issue Exercise of options / services provided

(If issued as consideration for the
acquisition of assets, clearly
identify those assets)

6a Is the entity an +eligible entity No

that has obtained security holder
approval under rule 7.1A?

If Yes, complete sections 6b – 6h

in relation to the +securities the
subject of this Appendix 3B, and
comply with section 6i

6b The date the security holder N/A

resolution under rule 7.1A was
passed

6c Number of +securities issued N/A

without security holder approval
under rule 7.1

+ See chapter 19 for defined terms.

Appendix 3B Page 2 04/03/2013

 Appendix 3B
New issue announcement

6d Number of +securities issued N/A

with security holder approval
under rule 7.1A

6e Number of +securities issued N/A

with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)

6f Number of +securities issued N/A

under an exception in rule 7.2

6g If +securities issued under rule N/A

7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.

6h If +securities were issued under N/A

rule 7.1A for non-cash
consideration, state date on
which valuation of consideration
was released to ASX Market
Announcements

6i Calculate the entity’s remaining N/A

issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements

7 +Issue dates 19 November 2019

Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule
19.12). For example, the issue date for a pro rata
entitlement issue must comply with the
applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

Number +Class
+class all 126,755,464
8 Number and of Fully paid ordinary
+securities quoted on ASX shares
(including the +securities in
section 2 if applicable)

+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 3

Appendix 3B
New issue announcement

Number +Class

9 Number and +class of all 650,000 Options at $0.25 per

+securities not quoted on ASX
share expiring
(including the +securities in 28/11/2019
section 2 if applicable)
2,000,000 Options at $0.10 per
share expiring
23/07/2022

3,350,000 Options at $0.12 per

share expiring
23/07/2022

10 Dividend policy (in the case of a N/A

trust, distribution policy) on the
increased capital (interests)

Part 2 - Pro rata issue

11 Is security holder approval NA
required?

12 Is the issue renounceable or non- NA

renounceable?

13 Ratio in which the +securities will NA

be offered

+Class of +securities to which the

14 NA
offer relates

15 +Record date to determine NA

entitlements

16 Will holdings on different NA

registers (or subregisters) be
aggregated for calculating
entitlements?

17 Policy for deciding entitlements NA

in relation to fractions

+ See chapter 19 for defined terms.

Appendix 3B Page 4 04/03/2013

 Appendix 3B
New issue announcement

18 Names of countries in which the NA

entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.

Cross reference: rule 7.7.

19 Closing date for receipt of NA

acceptances or renunciations
20 Names of any underwriters NA

21 Amount of any underwriting fee NA

or commission

22 Names of any brokers to the issue N/A

23 Fee or commission payable to the N/A

broker to the issue

24 Amount of any handling fee N/A

payable to brokers who lodge
acceptances or renunciations on
behalf of security holders

25 If the issue is contingent on N/A

security holders’ approval, the
date of the meeting

26 Date entitlement and acceptance NA

form and offer documents will be
sent to persons entitled

27 If the entity has issued options, NA

and the terms entitle option
holders to participate on exercise,
the date on which notices will be
sent to option holders

28 Date rights trading will begin (if N/A

applicable)

29 Date rights trading will end (if N/A

applicable)

+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 5

Appendix 3B
New issue announcement

30 How do security holders sell their N/A

entitlements in full through a
broker?

31 How do security holders sell part N/A

of their entitlements through a
broker and accept for the
balance?

32 How do security holders dispose N/A

of their entitlements (except by
sale through a broker)?

+Issue
33 date NA

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of +securities
(tick one)

(a) +Securities described in Part 1

(b) All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,
employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible
securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities NOT APPLICABLE

Tick to indicate you are providing the information or

documents

35 If the +securities are +equity securities, the names of the 20 largest holders of the
additional +securities, and the number and percentage of additional +securities
held by those holders

36 If the +securities are +equity securities, a distribution schedule of the additional

+securities setting out the number of holders in the categories

1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over

+ See chapter 19 for defined terms.

Appendix 3B Page 6 04/03/2013

 Appendix 3B
New issue announcement

37 A copy of any trust deed for the additional +securities

Entities that have ticked box 34(b) NOT APPLICABLE

38 Number of +securities for which N/A

+quotation is sought

39 +Class of +securities for which N/A

quotation is sought

40 Do the +securities rank equally in N/A

all respects from the +issue date
with an existing +class of quoted
+securities?

If the additional +securities do not

rank equally, please state:
• the date from which they do
• the extent to which they
participate for the next
dividend, (in the case of a trust,
distribution) or interest
payment
• the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest
payment

41 Reason for request for quotation N/A

now
Example: In the case of restricted securities, end
of restriction period

(if issued upon conversion of

another +security, clearly identify
that other +security)

Number +Class

42 Number and +class of all N/A N/A

+securities quoted on ASX
(including the +securities in clause
38)

+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 7

Appendix 3B
New issue announcement

Quotation agreement

1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX

may quote the +securities on any conditions it decides.

2 We warrant the following to ASX.

• The issue of the +securities to be quoted complies with the law and is
not for an illegal purpose.

• There is no reason why those +securities should not be granted

+quotation.

• An offer of the +securities for sale within 12 months after their issue will
not require disclosure under section 707(3) or section 1012C(6) of the
Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able
to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to
any applications received by us in relation to any +securities to be
quoted and that no-one has any right to return any +securities to be
quoted under sections 737, 738 or 1016F of the Corporations Act at the
time that we request that the +securities be quoted.

• If we are a trust, we warrant that no person has the right to return the
+securities to be quoted under section 1019B of the Corporations Act at

the time that we request that the +securities be quoted.

3 We will indemnify ASX to the fullest extent permitted by law in respect of any
claim, action or expense arising from or connected with any breach of the
warranties in this agreement.

4 We give ASX the information and documents required by this form. If any
information or document is not available now, we will give it to ASX before
+quotation of the +securities begins. We acknowledge that ASX is relying on

the information and documents. We warrant that they are (will be) true and
complete.

Sign here: ............................................................ Date: 19 November 2019

(Director/Company secretary)

Print name: Heath Roberts..................

== == == == ==

+ See chapter 19 for defined terms.

Appendix 3B Page 8 04/03/2013

 Appendix 3B
New issue announcement

Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A
for eligible entities
Introduced 01/08/12 Amended 04/03/13

Part 1 N/A - NO LR 7.1A APPROVAL

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated

Insert number of fully paid +ordinary

securities on issue 12 months before the
+issue date or date of agreement to issue

Add the following:

• Number of fully paid +ordinary

securities issued in that 12 month
period under an exception in rule 7.2

• Number of fully paid +ordinary

securities issued in that 12 month
period with shareholder approval

• Number of partly paid +ordinary

securities that became fully paid in that
12 month period

Note:
• Include only ordinary securities here –
other classes of equity securities
cannot be added
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
Subtract the number of fully paid
+ordinary securities cancelled during that

12 month period

“A”

+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 9

Appendix 3B
New issue announcement

Step 2: Calculate 15% of “A”

“B” 0.15

[Note: this value cannot be changed]

Multiply “A” by 0.15

Step 3: Calculate “C”, the amount of placement capacity under rule

7.1 that has already been used

Insert number of +equity securities issued

or agreed to be issued in that 12 month
period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under

rule 7.1 or rule 7.4

Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
“C” -

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining

placement capacity under rule 7.1

“A” x 0.15

Note: number must be same as shown in

Step 2

Subtract “C”

Note: number must be same as shown in

Step 3

Total [“A” x 0.15] – “C” [Note: this is the remaining placement

capacity under rule 7.1]

+ See chapter 19 for defined terms.

Appendix 3B Page 10 04/03/2013

 Appendix 3B
New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated

“A”

Note: number must be same as shown in

Step 1 of Part 1

Step 2: Calculate 10% of “A”

“D” 0.10

Note: this value cannot be changed

Multiply “A” by 0.10

Step 3: Calculate “E”, the amount of placement capacity under rule

7.1A that has already been used

Insert number of +equity securities issued

or agreed to be issued in that 12 month
period under rule 7.1A

Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as
separate line items
“E”

+ See chapter 19 for defined terms.

04/03/2013 Appendix 3B Page 11

Appendix 3B
New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining

placement capacity under rule 7.1A

“A” x 0.10

Note: number must be same as shown in

Step 2

Subtract “E”

Note: number must be same as shown in

Step 3

Total [“A” x 0.10] – “E”

Note: this is the remaining placement

capacity under rule 7.1A

+ See chapter 19 for defined terms.

Appendix 3B Page 12 04/03/2013

 Appendix 3Y
Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11

Name of entity SciDev Ltd

ABN 25 001 150 849

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.

Name of Director Lewis UTTING

Date of last notice 16/08/2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.

Direct or indirect interest Direct

Nature of indirect interest Not Applicable

(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.

Date of change 19112019

No. of securities held prior to change 330,221 fully paid ordinary shares (Lewis
Utting), 4,500,000 fully paid ordinary
shares (Lehos and Utting Family Trust)

500,000 options: expiry 28112019, exercise

price $0.25

2,000,000 options: expiry 23072022,

exercise price $0.10.

Class Refer above

+ See chapter 19 for defined terms.

Appendix 3Y Page 1 28/11/2018

Appendix 3Y
Change of Director’s Interest Notice

Number acquired 500,000 shares on exercise of $0.25

options:

Number disposed 0

Value/Consideration $0.25 per option / $125,000

Note: If consideration is non-cash, provide details and estimated
valuation

No. of securities held after change 330,221 fully paid ordinary shares (Lewis
Utting), 5,000,000 fully paid ordinary
shares (Lehos and Utting Family Trust)

1,600,000 options: expiry 23072022,

exercise price $0.10 (corrected).

Nature of change Exercise of options

Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.

Detail of contract NIL / NOT APPLICABLE

Nature of interest

Name of registered holder

(if issued securities)

Date of change

No. and class of securities to which

interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed

Interest acquired

Interest disposed

+ See chapter 19 for defined terms.

Appendix 3Y Page 2 28/11/2018

 Appendix 3Y
Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation

Interest after change

Part 3 – +Closed period

Were the interests in the securities or contracts detailed NO / NOT APPLICABLE

above traded during a +closed period where prior written
clearance was required?

If so, was prior written clearance provided to allow the trade NA

to proceed during this period?

If prior written clearance was provided, on what date was this NA

provided?

+ See chapter 19 for defined terms.

Appendix 3Y Page 3 28/11/2018